Venue: Virtual
Date: 22/03/2021
Time: 14:00 - 18:00
The Embassy of Denmark in Washington, DC and The Danish Medicines Agency are proud to present a 4-part virtual seminar series in collaboration with the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Each session will focus on a specific theme addressing related topics and incorporate recent examples and relevant cases. Sessions will be interactive with a Q&A period following each presentation. Below are the session titles and a detailed description of each can be read in the Announcement Registration attached in the Agenda section.
Why attend:
Who should attend:
In the attached announcement registration, you can read more about:
Practical information:
The registration fee of DKK 1500 per person includes participation in all sessions, materials, a certificate of participation, session recordings, and the opportunity for a brief 1:1 consultation with FDA/EMA officials. Registration for single sessions is not allowed . Deadline for registration is March 18, 2021
For more information contact:
Elizabeth Dempsey Becker
Team Leader, Health & Life Sciences North America
Embassy of Denmark, Washington, DC
E-mail: elibec@um.dk
Phone: +1 202 797 5310